Central Nervous System Neoplasms
"Central Nervous System Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
Descriptor ID |
D016543
|
MeSH Number(s) |
C04.588.614.250 C10.551.240
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Neoplasms".
This graph shows the total number of publications written about "Central Nervous System Neoplasms" by people in this website by year, and whether "Central Nervous System Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 2 | 2 | 4 |
1996 | 2 | 2 | 4 |
1997 | 2 | 0 | 2 |
1998 | 1 | 1 | 2 |
1999 | 1 | 2 | 3 |
2000 | 1 | 3 | 4 |
2001 | 1 | 1 | 2 |
2002 | 3 | 1 | 4 |
2003 | 4 | 1 | 5 |
2004 | 6 | 2 | 8 |
2005 | 2 | 2 | 4 |
2006 | 6 | 1 | 7 |
2007 | 8 | 1 | 9 |
2008 | 10 | 2 | 12 |
2009 | 4 | 1 | 5 |
2010 | 9 | 2 | 11 |
2011 | 10 | 1 | 11 |
2012 | 2 | 0 | 2 |
2013 | 5 | 0 | 5 |
2014 | 15 | 1 | 16 |
2015 | 6 | 0 | 6 |
2016 | 12 | 4 | 16 |
2017 | 15 | 1 | 16 |
2018 | 12 | 3 | 15 |
2019 | 12 | 3 | 15 |
2020 | 15 | 0 | 15 |
2021 | 14 | 0 | 14 |
2022 | 12 | 0 | 12 |
2023 | 14 | 0 | 14 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Central Nervous System Neoplasms" by people in Profiles.
-
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors. Pediatr Blood Cancer. 2024 Mar; 71(3):e30817.
-
Capturing evolving definitions of 12 select rare CNS tumors: a timely report from CBTRUS and NCI-CONNECT. J Neurooncol. 2023 Nov; 165(2):279-290.
-
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. J Hematol Oncol. 2023 11 09; 16(1):111.
-
Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019. J Natl Cancer Inst. 2023 11 08; 115(11):1337-1354.
-
Identification of health-related quality of life profiles among long-term survivors of primary central nervous system tumors. J Neurooncol. 2023 Oct; 165(1):181-190.
-
Clinical impact of molecular profiling in rare brain tumors. Curr Opin Neurol. 2023 Dec 01; 36(6):579-586.
-
Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors. Neuro Oncol. 2023 09 05; 25(9):1698-1708.
-
PRIMARY CENTRAL NERVOUS SYSTEM AND VITREORETINAL LYMPHOMA MIMICKING VIRAL RETINITIS IN A YOUNG PATIENT. Retin Cases Brief Rep. 2023 Sep 01; 17(5):567-571.
-
Fetal growth and pediatric cancer: A pan-cancer analysis in 7000 cases and 37?000 controls. Int J Cancer. 2024 01 01; 154(1):41-52.
-
The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta-analysis. Pediatr Blood Cancer. 2023 10; 70(10):e30601.